Meet the Authors

Brian Williams

Senior Vice President, Commercialization

Chris Zealey

Principal, Science and Strategy

Navigating success during a rare disease product launch

In this Pharmaceutical Executive presentation, our experts, Kapil Raina, Chris Zealey, and Brian Williams, explore insights on successfully launching products in rare disease markets. They cover key parameters for success and best practices for planning, timing, and budgeting specifically tailored for rare disease product launches.

Commercial Conversation Videos

Excerpts from our Pharmaceutical Executive presentation.

Rare Disease Landscape: Why You Need a Different Launch Playbook (VIDEO)

Explore the evolving landscape of rare diseases, focusing on patients’ diagnostic and treatment challenges. We’ll discuss competitive dynamics and tailored launch strategies to navigate this complex market.

What we heard from CCOs (VIDEO)

Gain insights from executives on launching in the rare disease market, focusing on cash flow management, hiring strategies, and stakeholder engagement. It emphasizes adaptability and balancing expertise with a startup mindset for success.

Parameters for Success (VIDEO)

The video outlines key success factors in rare disease markets, focusing on a patient-centered approach through the five P’s: People, Product, Payers, Promotion, and Placement

Best Practices – Budget-Timing (VIDEO)

The video outlines best planning, timing, and budgeting practices in rare disease product launches and features insights from medical, marketing, and market access experts.

Meet the Authors

Brian Williams

Senior Vice President, Commercialization

Chris Zealey

Principal, Science and Strategy

Let's Talk

Herspiegel is a leading professional services firm helping biotech start-ups and the world’s largest pharmaceutical companies navigate the path from science to brand performance and change patients’ lives. We are committed to using strategic insights from medical to commercial to market access to solve critical problems.